TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24617235

Group type: EXPERIMENTAL
Intervention: Acupuncture bloodletting combined with penicillin
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Acupuncture bloodletting
Number of subjects: 150

Group type: COMPARATOR
Intervention: Penicillin
Number of subjects: 150
Study: 20840874

Group type: EXPERIMENTAL
Intervention: Reminder about the txt2stop trial plus a message that there were only 300 places left
Number of subjects: 1862

Group type: COMPARATOR
Intervention: Reminder about the trial only
Number of subjects: 1862
Study: 18318773

Group type: EXPERIMENTAL
Intervention: Udenafil 25 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Udenafil 50 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Udenafil 100 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Udenafil 200 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Udenafil 300 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Udenafil 100 mg (multiple dose)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Udenafil 200 mg (multiple dose)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (single dose)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (multiple dose)
Number of subjects: 40
Study: 16927920

Group type: EXPERIMENTAL
Intervention: Systolic pressure variations (SPV) > 12 mmHg
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Delta down > 5 mmHg
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: SPV ≤ 12 mmHg
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Delta down = 5 mmHg
Number of subjects: 50

Group type: COMPARATOR
Intervention: Classic pressure parameters (MAP, CVP, PCWP)
Number of subjects: 50
Study: 12830439

Group type: EXPERIMENTAL
Intervention: Short daily hemodialysis (HD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Long nocturnal hemodialysis (HD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional thrice-weekly hemodialysis (HD)
Number of subjects: 0
Study: 14639559

Group type: EXPERIMENTAL
Intervention: Aerobic training with a leg cycle ergometer for 8 weeks
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 92
Study: 11172996

Group type: EXPERIMENTAL
Intervention: Fastrach group (endotracheal tube alone)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Fastrach/Trachlight group (endotracheal tube with Trachlight)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Fastrach group
Number of subjects: 172

Group type: COMPARATOR
Intervention: Fastrach group and Fastrach/Trachlight group
Number of subjects: 172
Study: 8887197

Group type: EXPERIMENTAL
Intervention: Growth hormone-releasing factor (GRF), 1,000 mg/day, given in addition to follicle-stimulating hormone (FSH)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Follicle-stimulating hormone (FSH) alone (control group)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Growth hormone-releasing factor (GRF) with FSH
Number of subjects: 42
Study: 1355943

Group type: EXPERIMENTAL
Intervention: Carnitine and cobamamide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard nonspecific treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined use of carnitine and cobamamide
Number of subjects: 0
Study: 6148163

Group type: EXPERIMENTAL
Intervention: Thyroid stimulating antibody (TSAb) determinations before and at the end of treatment
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: End-treatment TSAb levels greater than 350%
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: End-treatment TSAb levels less than 350% or negative
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: TSAb determined during follow-up
Number of subjects: 55
Study: 3789694

Group type: EXPERIMENTAL
Intervention: Interferon (3 X 10(6) IU of alpha 2b interferon, administered by subcutaneous injection, three times weekly for 12 weeks)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo (administered by subcutaneous injection, three times weekly for 12 weeks)
Number of subjects: 37
Study: 31615456

Group type: EXPERIMENTAL
Intervention: Interactive smartphone application (APP) for weight, diet, and physical activity tracking, including educational videos and real-time interaction with health professionals.
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Secondary outcomes
Number of subjects: 200
Study: 28177728

Group type: EXPERIMENTAL
Intervention: Daily light physical activity for a minimum of 30 minutes starting a maximum of 30 minutes after a meal for 12 weeks
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group maintained their usual lifestyle
Number of subjects: 56
Study: 25547711

Group type: EXPERIMENTAL
Intervention: escitalopram
Number of subjects: 1008

Group type: EXPERIMENTAL
Intervention: sertraline
Number of subjects: 1008

Group type: EXPERIMENTAL
Intervention: venlafaxine‐extended release
Number of subjects: 1008

Group type: COMPARATOR
Intervention: cognitive tests
Number of subjects: 1008
Study: 23442284

Group type: EXPERIMENTAL
Intervention: Carbohydrate (CHO)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 6
Study: 21489062

Group type: EXPERIMENTAL
Intervention: Internal focus on self
Number of subjects: 30

Group type: COMPARATOR
Intervention: External focus on surroundings
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Fear of bodily sensations
Number of subjects: 30
Study: 19430829

Group type: EXPERIMENTAL
Intervention: Laparoscopic procedure (n = 52)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Open procedure (n = 49)
Number of subjects: 109
Study: 16563900

Group type: EXPERIMENTAL
Intervention: 5% dextrose infusion (1 L) prior to catheterization
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (no dextrose infusion)
Number of subjects: 49
Study: 15560689

Group type: EXPERIMENTAL
Intervention: 100 IU of Follitropin beta
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 200 IU of Follitropin beta
Number of subjects: 60
Study: 11746615

Group type: EXPERIMENTAL
Intervention: tolcapone 100 mg t.i.d. (possible increase to 200 mg t.i.d.)
Number of subjects: 203

Group type: COMPARATOR
Intervention: pergolide titrated to a maximum dose of 5 mg/day (mean final dose 2.2 mg/day)
Number of subjects: 203
Study: 9431631

Group type: EXPERIMENTAL
Intervention: Physiotherapy and patient education program during pregnancy
Number of subjects: 362

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 362
Study: 8374232

Group type: EXPERIMENTAL
Intervention: TRUE VISTA bifocal IOL (TV)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 3M diffractive bifocal IOL (3M)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Nordan Aspheric Varifocal Silicone IOL (VF)
Number of subjects: 33
Study: 2442506

Group type: EXPERIMENTAL
Intervention: Nisoldipine (10-40 mg daily)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Verapamil (40-80 mg three times daily)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Nifedipine (long-acting form, 20-80 mg daily)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 31618099

Group type: EXPERIMENTAL
Intervention: Psychological Entitlement Scale (PES)
Number of subjects: 523

Group type: EXPERIMENTAL
Intervention: PES-G (grandiose-based entitlement)
Number of subjects: 523

Group type: EXPERIMENTAL
Intervention: PES-V (vulnerable-based entitlement)
Number of subjects: 523
Study: 29846661

Group type: EXPERIMENTAL
Intervention: Optia
Number of subjects: 0

Group type: COMPARATOR
Intervention: COBE
Number of subjects: 0
Study: 28315068

Group type: EXPERIMENTAL
Intervention: nab-paclitaxel 150 mg/m2 (nP150)
Number of subjects: 1207

Group type: EXPERIMENTAL
Intervention: nab-paclitaxel 125 mg/m2 (nP125)
Number of subjects: 1207

Group type: COMPARATOR
Intervention: paclitaxel 80 mg/m2 (P80)
Number of subjects: 1207
Study: 26508749

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 386

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 386
Study: 24216771

Group type: EXPERIMENTAL
Intervention: Pinna cue‐preserving microphone position
Number of subjects: 17

Group type: COMPARATOR
Intervention: Microphone position not preserving pinna cues
Number of subjects: 17
Study: 21358428

Group type: EXPERIMENTAL
Intervention: Dynamic stretching
Number of subjects: 18

Group type: COMPARATOR
Intervention: Static stretching
Number of subjects: 18
Study: 18089850

Group type: EXPERIMENTAL
Intervention: Arm A: 6 weeks of daily prednisone and weekly vinblastine followed by 18 weeks of daily 6‐mercaptopurine with vinblastine/prednisone pulses
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Arm B: Etoposide added to the regimen of Arm A
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Arm B
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Arm A
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Arm B (intensified treatment)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Arm A LCH‐I
Number of subjects: 193
Study: 16514225

Group type: EXPERIMENTAL
Intervention: 1 ml/kg of 25 microg/kg butorphanol in combination with 0.25% bupivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: 1 ml/kg of 0.25% bupivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: 1 ml/kg of 25 microg/kg butorphanol diluted in normal saline
Number of subjects: 60
Study: 14606508

Group type: EXPERIMENTAL
Intervention: Ice hockey training
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Cessation of ice hockey training
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Continued ice hockey training
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 68
Study: 10790348

Group type: EXPERIMENTAL
Intervention: Inhalation of 20 ppm nitric oxide (NO)
Number of subjects: 14
Study: 9292747

Group type: EXPERIMENTAL
Intervention: Conformal radiotherapy
Number of subjects: 130

Group type: COMPARATOR
Intervention: Conventional radiotherapy
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Conformal radiotherapy with sucralfate
Number of subjects: 130

Group type: COMPARATOR
Intervention: Conventional radiotherapy without sucralfate
Number of subjects: 130
Study: 8347966

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Paracetamol
Number of subjects: 395

Group type: COMPARATOR
Intervention: No drug treatment
Number of subjects: 395
Study: 3510014

Group type: EXPERIMENTAL
Intervention: Intravenous antibiotics (2 g for eight doses)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Irrigation of uterus and peritoneum with 2 g of antibiotic
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Combination of intravenous and irrigation
Number of subjects: 158

Group type: COMPARATOR
Intervention: Control group (no antibiotic prophylaxis)
Number of subjects: 158
Study: 30646931

Group type: EXPERIMENTAL
Intervention: FOB-guided method (F)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional method (C)
Number of subjects: 50
Study: 28703859

Group type: EXPERIMENTAL
Intervention: 19 or 38 mg iron for 60 days
Number of subjects: 692

Group type: EXPERIMENTAL
Intervention: Educational letter advising low ferritin levels
Number of subjects: 692

Group type: COMPARATOR
Intervention: Educational letter lacking specific recommendation
Number of subjects: 692

Group type: EXPERIMENTAL
Intervention: Iron pills
Number of subjects: 692
Study: 25731946

Group type: EXPERIMENTAL
Intervention: Module-based training with skills-lab course followed by 20 supervised Lichtenstein hernia repairs
Number of subjects: 18

Group type: COMPARATOR
Intervention: Conventional training
Number of subjects: 18
Study: 23905375

Group type: EXPERIMENTAL
Intervention: Shenfu Injection (SFI) at 1.5 mL/kg (dissolved in 250 mL 5% glucose solution), administered intravenously once daily for 5 days before operation.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Normal saline (control group), equal dose to SFI group, administered 30 min before anesthesia induction.
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups assessed with mini-mental state examination (MMSE) scale.
Number of subjects: 30
Study: 21568982

Group type: EXPERIMENTAL
Intervention: i-gel
Number of subjects: 50

Group type: COMPARATOR
Intervention: LMA-Unique
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: i-gel (mild subgroup)
Number of subjects: 50

Group type: COMPARATOR
Intervention: LMA-Unique (mild subgroup)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: i-gel (moderate subgroup)
Number of subjects: 50

Group type: COMPARATOR
Intervention: LMA-Unique (moderate subgroup)
Number of subjects: 50
Study: 19123002

Group type: EXPERIMENTAL
Intervention: Cisplatin 100 mg/m² on a 21-day schedule (group A)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cisplatin 40 mg/m² on a 7-day schedule (group B)
Number of subjects: 50
Study: 16820373

Group type: EXPERIMENTAL
Intervention: Tranilast 100 mg, 3 times daily (T(+) group)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (T(‐) group)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Tranilast treatment vs Control
Number of subjects: 20
Study: 15585141

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (40 mg or 0.01 ml/kg, subcutaneous injection, every 12 hours)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 17
Study: 11027423

Group type: EXPERIMENTAL
Intervention: 13-Cis retinoic acid at a dose of 0.75 mg/kg/day
Number of subjects: 175

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 175
Study: 9408562

Group type: EXPERIMENTAL
Intervention: Low frequency fore-and-aft vibration with a 4-point harness
Number of subjects: 12

Group type: COMPARATOR
Intervention: Low frequency fore-and-aft vibration without a harness
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Higher frequencies of lateral vibration
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Random vibration
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Horizontal vibration in the range 1 to 4 Hz
Number of subjects: 12
Study: 8436775

Group type: EXPERIMENTAL
Intervention: 1000 mg oral calcium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2944687

Group type: EXPERIMENTAL
Intervention: Supine posture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Upright posture
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inflation of antishock trousers
Number of subjects: 0
Study: 29186389

Group type: EXPERIMENTAL
Intervention: Colchicine 0.6 mg orally twice daily for 10 days
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 100
Study: 26994634

Group type: EXPERIMENTAL
Intervention: Supportive medications (any)
Number of subjects: 947

Group type: EXPERIMENTAL
Intervention: Opioid pain medications
Number of subjects: 947

Group type: EXPERIMENTAL
Intervention: Non-opioid psychotropic medications
Number of subjects: 947
Study: 24630293

Group type: EXPERIMENTAL
Intervention: Single-port access (SPA) laparoscopic ovarian cystectomy
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Two-port access (TPA) laparoscopic ovarian cystectomy
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Four-port access (FPA) laparoscopic ovarian cystectomy
Number of subjects: 87
Study: 22795280

Group type: EXPERIMENTAL
Intervention: Ticagrelor (180 mg loading/90 mg twice daily)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Clopidogrel (600 mg loading/75 mg daily)
Number of subjects: 76
Study: 20454968

Group type: EXPERIMENTAL
Intervention: Ivabradine
Number of subjects: 4954
Study: 17295559

Group type: EXPERIMENTAL
Intervention: Penn Resiliency Program (PRP)
Number of subjects: 697

Group type: COMPARATOR
Intervention: Penn Enhancement Program (PEP)
Number of subjects: 697

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 697
Study: 15764959

Group type: EXPERIMENTAL
Intervention: Alendronate (70 mg weekly for 48 weeks) + vitamin D (400 IU daily) + calcium (1000 mg daily)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Vitamin D (400 IU daily) + calcium (1000 mg daily)
Number of subjects: 31
Study: 11868620

Group type: EXPERIMENTAL
Intervention: Prodefense rape story
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Proprosecution rape story
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonrape story
Number of subjects: 0
Study: 10661043

Group type: EXPERIMENTAL
Intervention: Vaccinated employees
Number of subjects: 1710

Group type: COMPARATOR
Intervention: Nonvaccinated employees
Number of subjects: 1710

Group type: EXPERIMENTAL
Intervention: Cost savings from vaccination
Number of subjects: 1710
Study: 7850589

Group type: EXPERIMENTAL
Intervention: Ritodrine hydrochloride 10 mg by mouth
Number of subjects: 5521

Group type: COMPARATOR
Intervention: Monitoring without treatment
Number of subjects: 5521
Study: 1803833

Group type: EXPERIMENTAL
Intervention: Midazolam 0.1 mg/kg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Midazolam 0.05 mg/kg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Diazepam 0.15 mg/kg
Number of subjects: 90

Group type: COMPARATOR
Intervention: Flumazenil 1 mg
Number of subjects: 90

Group type: COMPARATOR
Intervention: Flumazenil 0.5 mg
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 6851262

Group type: EXPERIMENTAL
Intervention: gentamicin and cloxacillin
Number of subjects: 36

Group type: COMPARATOR
Intervention: cephalothin
Number of subjects: 36
Study: 31918584

Group type: EXPERIMENTAL
Intervention: ASSIP intervention group (N = 60)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (N = 60)
Number of subjects: 120
Study: 31385881

Group type: EXPERIMENTAL
Intervention: ICU recovery program
Number of subjects: 232

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 232
Study: 29666071

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) with everolimus-eluting stents
Number of subjects: 1037

Group type: COMPARATOR
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 1037

Group type: EXPERIMENTAL
Intervention: Elevated BNP levels
Number of subjects: 1037

Group type: COMPARATOR
Intervention: Normal BNP levels
Number of subjects: 1037

Group type: EXPERIMENTAL
Intervention: PCI versus CABG in patients with elevated BNP
Number of subjects: 1037

Group type: COMPARATOR
Intervention: PCI versus CABG in patients with normal BNP
Number of subjects: 1037
Study: 23828124

Group type: EXPERIMENTAL
Intervention: Whole-body vibration exercise group (n=15)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Exercise group (n=15)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Usual-care control group (n=16)
Number of subjects: 46
Study: 20878837

Group type: EXPERIMENTAL
Intervention: Poor physical health (bottom two quintiles)
Number of subjects: 2967

Group type: EXPERIMENTAL
Intervention: Greater hostility
Number of subjects: 2967
Study: 19150206

Group type: EXPERIMENTAL
Intervention: Real Men Are Safe (REMAS; five sessions containing information, motivational exercises, and skills training)
Number of subjects: 590

Group type: EXPERIMENTAL
Intervention: Real Men Are Safe (REMAS; five sessions)
Number of subjects: 590

Group type: COMPARATOR
Intervention: HIV education (HIV‐Ed; one session containing HIV prevention information)
Number of subjects: 590
Study: 17381398

Group type: EXPERIMENTAL
Intervention: Open management of the abdomen (group A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Closed management of the abdomen (group B)
Number of subjects: 40
Study: 15456079

Group type: EXPERIMENTAL
Intervention: peginterferon alpha-2a 180 microg once weekly
Number of subjects: 22

Group type: COMPARATOR
Intervention: peginterferon alpha-2b 1.0 microg/kg once weekly
Number of subjects: 22
Study: 11373253

Group type: EXPERIMENTAL
Intervention: 30 g of alcohol per day (as beer, red wine or spirits) for 6 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Mineral water
Number of subjects: 60
Study: 9170763

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) including detailed explanation of obsessive thoughts, exposure, response prevention, cognitive restructuring, and relapse prevention.
Number of subjects: 29

Group type: COMPARATOR
Intervention: Waiting-list condition (Control)
Number of subjects: 29
Study: 8190534

Group type: EXPERIMENTAL
Intervention: High titer Edmonston-Zagreb measles vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medium titer Edmonston-Zagreb measles vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 0
Study: 3296979

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide with amiloride
Number of subjects: 130
Study: 29189583

Group type: EXPERIMENTAL
Intervention: Strength training only (S)
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Aerobic training only (A)
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Intrasession aerobic and strength training (AS)
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Intrasession strength and aerobic training (SA)
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Concurrent training performed in different sessions (CT)
Number of subjects: 245

Group type: COMPARATOR
Intervention: Control group (no training regimen) (C)
Number of subjects: 245
Study: 29781785

Group type: EXPERIMENTAL
Intervention: 100% watermelon juice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 27155142

Group type: EXPERIMENTAL
Intervention: Acute stress induced by the Trier Social Stress Test
Number of subjects: 24

Group type: COMPARATOR
Intervention: Non-stress condition (control)
Number of subjects: 24
Study: 24763755

Group type: EXPERIMENTAL
Intervention: Topical corticosteroids administered within 2 to 3 days of antibiotic therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical corticosteroids administered after 4 or more days of antibiotic therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical corticosteroids administered earlier in patients with non-Nocardia keratitis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical corticosteroids administered earlier in patients with no topical antibiotic use before enrollment
Number of subjects: 0
Study: 22426307

Group type: EXPERIMENTAL
Intervention: Teriparatide 20 μg/day
Number of subjects: 623

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 623
Study: 20097461

Group type: EXPERIMENTAL
Intervention: Intensive therapy (RAS inhibitors [ACE inhibitors plus ARBs] plus high‐dose statin and spironolactone)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Conventional therapy (ACE inhibitors with low‐dose statin)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Intensive therapy
Number of subjects: 128